Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jennifer Temel, MD
Massachusetts General Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Regional Cancer Centre Indira Gandhi Institute of Medical Sciences
Patna, Bihar, India
- Cancer Clinic 208
Nagpur, Maharashtra, India
- Noble Hospital
Pune, Maharashtra, India
- Ruby Hall Clinic
Pune, Maharashtra, India
- Kaushalya Medical Foundation Trust Hospital
Thane, Maharashtra, India
- Searoc Cancer Center
Jaipur, Rajasthan, India
- Jawaharlal Nehru Cancer Hospital and Research Centre
Bhopal, India
- Kamakshi Memorial Hospital
Chennai, India
- Dharamshila Cancer Hospital and Research Center
Delhi, India
- Bhagwan Mahaveer Cancer Hospital and Resaerch Center
Jaipur, India
- Birla Cancer Centre Sms Medical College Hospital
Jaipur, India
- Kodlikeri Memorial Hospital
Maharashtra, India
- Jaslok Hospital and Research Centre
Mumbai, India
- Shatabdi Super Speciality Hospital
Mumbai Naka, Nasik, India
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Osler Medical
Melbourne, Florida, United States
- Augusta Oncology Associates
Augusta, Georgia, United States
- South Georgia Medical Center
Valdosta, Georgia, United States
- Investigative Clinical Research of Indiana
Indianapolis, Indiana, United States
- John Hopkins University
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Caritas St. Elizabeth'S Medical Center
Boston, Massachusetts, United States
- Dana Farber Cancer Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- the West Clinic
Corinth, Mississippi, United States
- the West Clinic
Southaven, Mississippi, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Duke University Medical Center
Durham, North Carolina, United States
- South Carolina Cancer Specialists
Hilton Head Island, South Carolina, United States
- the West Clinic
Memphis, Tennessee, United States
- Baylor College of Medicine/vamc
Houston, Texas, United States
- the Methodist Hospital Research Institute
Houston, Texas, United States
- North West Medical Specialties, Pllc
Puyallup, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 31 Dec 2009
- Completion
- 31 Dec 2009
- Last update posted
- 14 Apr 2017
- Registered enrollment
- 228
- Registry id
- NCT00622193
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.